Loomis, Sayles & Company
XRAY icon

Loomis, Sayles & Company’s Dentsply Sirona XRAY Stock Holding History

Loomis, Sayles & Company’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54
Closed -$3K – 1061
2022
Q1 		$3K Buy
+54
New +$2.85K ﹤0.01% 911
2018
Q2 		– Sell
-141,007
Closed -$7.09M – 931
2018
Q1 		$7.09M Sell
141,007
-28,158
-17% -$1.66M 0.02% 491
2017
Q4 		$11.1M Sell
169,165
-73,794
-30% -$4.69M 0.02% 414
2017
Q3 		$14.5M Sell
242,959
-19,774
-8% -$1.18M 0.03% 349
2017
Q2 		$17M Sell
262,733
-20,789
-7% -$1.31M 0.04% 299
2017
Q1 		$17.7M Buy
283,522
+36,636
+15% +$2.21M 0.04% 283
2016
Q4 		$14.3M Sell
246,886
-52,295
-17% -$3.09M 0.04% 351
2016
Q3 		$17.8M Sell
299,181
-67,515
-18% -$4.15M 0.05% 296
2016
Q2 		$22.8M Sell
366,696
-6,027
-2% -$371K 0.06% 234
2016
Q1 		$23M Buy
+372,723
New +$22M 0.07% 218

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Loomis, Sayles & Company's XRAY Position: Q2 2022 in Review

Loomis, Sayles & Company sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 54 shares — an estimated $3K sold.

Loomis, Sayles & Company first reported a position in XRAY in Q1 2016 and held it in 10 quarters. The position peaked at $23M in Q1 2016. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Loomis, Sayles & Company reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 54 Dentsply Sirona shares in Q2 2022, an estimated $3K.
  • Loomis, Sayles & Company first reported a position in Dentsply Sirona in Q1 2016 and held it in 10 quarters.
  • Loomis, Sayles & Company's Dentsply Sirona position peaked at $23M in Q1 2016.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Loomis, Sayles & Company's 13F filing for Q2 2022, filed 5 Aug 2022.